Blocking Hsp90ab1 with geldanamycin prevents UPR-induced activation and EMT, pointing to the UPR-Hsp90ab1 axis as a driver of tumor cell reprogramming [144]. The gene discussed is HSP90AB1; the disease is neoplasm.